These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11392157)

  • 1. [Usefulness of extracorporeal blood purification methods in prevention and treatment of cardiovascular diseases].
    Chrzanowski W
    Pol Arch Med Wewn; 2000 Oct; 104(4):685-93. PubMed ID: 11392157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extracorporeal methods for low-density lipoprotein apheresis in treating patients with severe forms of hereditary hypercholesterolemia. A review].
    Konovalov GA
    Ter Arkh; 1991; 63(10):111-9. PubMed ID: 1805407
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.
    Blessing F; Wang Y; Walli AK; Seidel D
    Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extracorporeal removal of cholesterol in familial hypercholesterolemia].
    Lupien PJ; Brun LD; Moorjani S; Gagné C; Awad J
    Union Med Can; 1979 May; 108(5):558-65. PubMed ID: 229607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The initial experience of using fraxiparin in extracorporeal detoxication in clinical cardiology].
    Sirenko IuN; Sychev OS; Reĭko MN; Shchupak MB; Sidorenko PI
    Klin Khir (1962); 1994; (12):23-5. PubMed ID: 9173120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The plasmoimmunosorption of low-density lipoproteins in the treatment of patients with hereditary hypercholesterolemia].
    Konovalov GA; Pokrovskiĭ SN; Trakht IN; Bokchubaev E; Volkova EI; Kukharchuk VV
    Ter Arkh; 1991; 63(7):65-70. PubMed ID: 1788813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
    Bosch T; Thiery J; Gurland HJ; Seidel D
    Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organizational aspects of extracorporeal blood correction service].
    Kruglov EE; Onoprienko GA; Shumskiĭ VI; Avash IuB; Solodkiĭ VA; Vatazin AV; Fomin AM
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2002; (5):50-1. PubMed ID: 12494580
    [No Abstract]   [Full Text] [Related]  

  • 10. Biphasic hemodynamic effects of LDL-apheresis in common carotid artery.
    Carallo C; Loprete A; Mazza G; Bellotti G; de Siena M; Serrao P; Vuoto ES; de Franceschi MS; Irace C; Gnasso A
    Clin Hemorheol Microcirc; 2015; 60(3):297-307. PubMed ID: 24787628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
    Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
    Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond dialysis: current and emerging blood purification techniques.
    Stegmayr B; Ramlow W; Balogun RA
    Semin Dial; 2012; 25(2):207-13. PubMed ID: 22428812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's going on in LDL apheresis.
    Onofrillo D; Accorsi P
    Transfus Apher Sci; 2007 Dec; 37(3):213-21. PubMed ID: 18054286
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D
    Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Automatization of the immuno-apheresis of hypercholesterolemic plasma in extracorporeal circulation].
    Michaely JP; Didelon J; Siadat M; Rivat C; Regnault V; Schooneman F; Stoltz JF
    Ann Med Interne (Paris); 1990; 141(7):608-10. PubMed ID: 2085240
    [No Abstract]   [Full Text] [Related]  

  • 20. [The basic principles of extracorporeal detoxication in military field surgery].
    Gurevich KIa; Vorob'ev AA; Glaznikov LA
    Voen Med Zh; 1991 Jul; (7):7-11. PubMed ID: 1957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.